Souza, I.N.O.; Barros-Aragão, F.G.Q.; Frost, P.S.; Figueiredo, C.P.; Clarke, J.R.
Late Neurological Consequences of Zika Virus Infection: Risk Factors and Pharmaceutical Approaches. Pharmaceuticals 2019, 12, 60.
https://doi.org/10.3390/ph12020060
AMA Style
Souza INO, Barros-Aragão FGQ, Frost PS, Figueiredo CP, Clarke JR.
Late Neurological Consequences of Zika Virus Infection: Risk Factors and Pharmaceutical Approaches. Pharmaceuticals. 2019; 12(2):60.
https://doi.org/10.3390/ph12020060
Chicago/Turabian Style
Souza, Isis N. O., Fernanda G. Q. Barros-Aragão, Paula S. Frost, Claudia P. Figueiredo, and Julia R. Clarke.
2019. "Late Neurological Consequences of Zika Virus Infection: Risk Factors and Pharmaceutical Approaches" Pharmaceuticals 12, no. 2: 60.
https://doi.org/10.3390/ph12020060
APA Style
Souza, I. N. O., Barros-Aragão, F. G. Q., Frost, P. S., Figueiredo, C. P., & Clarke, J. R.
(2019). Late Neurological Consequences of Zika Virus Infection: Risk Factors and Pharmaceutical Approaches. Pharmaceuticals, 12(2), 60.
https://doi.org/10.3390/ph12020060